Chia Kow to Rituximab
This is a "connection" page, showing publications Chia Kow has written about Rituximab.
Connection Strength
0.119
-
Use of rituximab and the risk of adverse clinical outcomes in COVID-19 patients with systemic rheumatic disease. Rheumatol Int. 2020 12; 40(12):2117-2118.
Score: 0.119
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.